{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:20:28Z","timestamp":1791951628961,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL135089"],"award-info":[{"award-number":["HL135089"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sex hormones and their respective receptors affect vascular function differently in men and women, so it is reasonable to assume they play a role in the sex differences in cardiovascular disease states. This review focuses on how the effects of testosterone on arterial vessels impact the female vasculature. In women with androgen-excess polycystic ovary syndrome, and in transgender men, testosterone exposure is associated with high blood pressure, endothelial dysfunction, and dyslipidemia. These relationships suggest that androgens may exert pathophysiological effects on the female vasculature, and these effects on the female vasculature appear to be independent from other co-morbidities of cardiovascular disease. There is evidence that the engagement of androgens with androgen receptor induces detrimental outcomes in the female cardiovascular system, thereby representing a potential causative link with sex differences and cardiovascular regulation. Gender affirming hormone therapy is the primary medical intervention sought by transgender people to reduce the characteristics of their natal sex and induce those of their desired sex. Transgender men, and women with androgen-excess polycystic ovary syndrome both represent patient groups that experience chronic hyperandrogenism and thus lifelong exposure to significant medical risk. The study of testosterone effects on the female vasculature is relatively new, and a complex picture has begun to emerge. Long-term research in this area is needed for the development of more consistent models and controlled experimental designs that will provide insights into the impact of endogenous androgen concentrations, testosterone doses for hormone therapy, and specific hormone types on function of the female cardiovascular system.<\/jats:p>","DOI":"10.1186\/s13293-020-00323-6","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T12:02:39Z","timestamp":1596024159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pathophysiological effects of androgens on the female vascular system"],"prefix":"10.1186","volume":"11","author":[{"given":"Tori","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6597-5031","authenticated-orcid":false,"given":"Nina S.","family":"Stachenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"323_CR1","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146\u2013603.","journal-title":"Circulation."},{"key":"323_CR2","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1074\/jbc.M306143200","volume":"279","author":"S Baron","year":"2004","unstructured":"Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, et al. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem. 2004;279:14579\u201386.","journal-title":"J Biol Chem"},{"key":"323_CR3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1210\/me.2002-0070","volume":"16","author":"CA Heinlein","year":"2002","unstructured":"Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol. 2002;16:2181\u20137.","journal-title":"Mol Endocrinol"},{"key":"323_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/er.2015-1034","volume":"36","author":"P Pihlajamaa","year":"2015","unstructured":"Pihlajamaa P, Sahu B, J\u00e4nne OA. Determinants of receptor- and tissue-specific actions in androgen signaling. Endocr Rev. 2015;36:357\u201384.","journal-title":"Endocr Rev"},{"key":"323_CR5","doi-asserted-by":"crossref","first-page":"H524","DOI":"10.1152\/ajpheart.00217.2016","volume":"313","author":"AC Boese","year":"2017","unstructured":"Boese AC, Kim SC, Yin KJ, Lee JP, Hamblin MH. Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. Am J Physiol Heart Circ Physiol. 2017;313:H524\u2013H45.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"323_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yfrne.2007.10.005","volume":"29","author":"CD Foradori","year":"2008","unstructured":"Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol. 2008;29:169\u201381.","journal-title":"Front Neuroendocrinol"},{"key":"323_CR7","doi-asserted-by":"crossref","first-page":"H1569","DOI":"10.1152\/ajpheart.00396.2018","volume":"315","author":"AE Stanhewicz","year":"2018","unstructured":"Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol-Heart Circulatory Physiol. 2018;315:H1569\u2013H88.","journal-title":"Am J Physiol-Heart Circulatory Physiol"},{"key":"323_CR8","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-14-0611","volume":"224","author":"V Torres-Estay","year":"2015","unstructured":"Torres-Estay V, Carreno DV, San Francisco IF, Sotomayor P, Godoy AS, Smith GJ. Androgen receptor in human endothelial cells. J Endocrinol. 2015;224:R131\u20137.","journal-title":"J Endocrinol"},{"key":"323_CR9","doi-asserted-by":"crossref","unstructured":"Lopes RAM, Neves KB, Pestana CR, Queiroz AL, Zanotto CZ, Chignalia AZ, et al. Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement. Am J Physiol-Heart Circ Physiol. 2014;306:H1485\u2013H94.","DOI":"10.1152\/ajpheart.00809.2013"},{"key":"323_CR10","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1161\/CIRCULATIONAHA.107.708768","volume":"116","author":"JE Nettleship","year":"2007","unstructured":"Nettleship JE, Jones TH, Channer KS, Jones RD. Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse. Circulation. 2007;116:2427.","journal-title":"Circulation."},{"key":"323_CR11","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1210\/jc.2005-1398","volume":"91","author":"G Bernini","year":"2006","unstructured":"Bernini G, Versari D, Moretti A, Virdis A, Ghiadoni L, Bardini M, et al. Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab. 2006;91:1691\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0735-1097(96)00570-0","volume":"29","author":"SJ Hutchison","year":"1997","unstructured":"Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, et al. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol. 1997;29:800\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"323_CR13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jsxm.2017.11.001","volume":"14","author":"T Kataoka","year":"2017","unstructured":"Kataoka T, Hotta Y, Maeda Y, Kimura K. Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine and oxidative stress in castrated rats. J Sex Med. 2017;14:1540\u20138.","journal-title":"J Sex Med"},{"key":"323_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/ebm1079","volume":"15","author":"SM Harman","year":"2010","unstructured":"Harman SM. Combined estrogen plus progestin may reduce coronary heart disease risk after 5\u2009years of use in postmenopausal women starting treatment within 10\u2009years of menopause. Evidence Based Medicine. 2010;15:69\u201370.","journal-title":"Evidence Based Medicine"},{"key":"323_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","volume":"8","author":"A Iorga","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8:33.","journal-title":"Biol Sex Differ"},{"key":"323_CR16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1113\/EP085148","volume":"101","author":"CW Usselman","year":"2016","unstructured":"Usselman CW, Stachenfeld NS, Bender JR. The molecular actions of oestrogen in the regulation of vascular health. Exp Physiol. 2016;101:356\u201361.","journal-title":"Exp Physiol"},{"key":"323_CR17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","volume":"24","author":"PY Liu","year":"2003","unstructured":"Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313\u201340.","journal-title":"Endocr Rev"},{"key":"323_CR18","unstructured":"Dixit KCS, Wu J, Smith LB, Hadoke PWF, Wu FCW. Androgens and coronary artery disease. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., editors. Endotext. South Dartmouth (MA)2000."},{"key":"323_CR19","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/jc.2009-2643","volume":"95","author":"R Calderon-Margalit","year":"2010","unstructured":"Calderon-Margalit R, Schwartz SM, Wellons MF, Lewis CE, Daviglus ML, Schreiner PJ, et al. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the \u201cCoronary Artery Risk Development in Young Adults\u201d women\u2019s study. J Clin Endocrinol Metab. 2010;95:4424\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR20","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399408000598","volume":"10","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med. 2008;10:e3.","journal-title":"Expert Rev Mol Med"},{"key":"323_CR21","doi-asserted-by":"crossref","unstructured":"Wenner MM, Haddadin AS, Taylor HS, Stachenfeld NS. Mechanisms contributing to low orthostatic tolerance in women: the influence of oestradiol. J Physiol. 2013.","DOI":"10.1113\/jphysiol.2012.247882"},{"key":"323_CR22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/HYPERTENSIONAHA.110.161570","volume":"57","author":"CC Wu","year":"2011","unstructured":"Wu CC, Cheng J, Zhang FF, Gotlinger KH, Kelkar M, Zhang Y, et al. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase. Hypertension. 2011;57:788\u201394.","journal-title":"Hypertension."},{"key":"323_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.08.037","volume":"204","author":"P Ouyang","year":"2009","unstructured":"Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2009;204:255\u201361.","journal-title":"Atherosclerosis."},{"key":"323_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.metabol.2011.06.005","volume":"61","author":"M Creatsa","year":"2012","unstructured":"Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism. 2012;61:193\u2013201.","journal-title":"Metabolism."},{"key":"323_CR25","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jcem.84.6.5824","volume":"84","author":"GP Bernini","year":"1999","unstructured":"Bernini GP, Sgro\u2019 M, Moretti A, Argenio GF, Barlascini CO, Cristofani R, et al. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab. 1999;84:2008\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR26","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1161\/ATVBAHA.114.304136","volume":"34","author":"R Calderon-Margalit","year":"2014","unstructured":"Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the coronary artery risk development in young adults women\u2019s study. Arterioscler Thromb Vasc Biol. 2014;34:2688\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"323_CR27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.02.020","volume":"247","author":"H Kische","year":"2016","unstructured":"Kische H, Gross S, Wallaschofski H, Volzke H, Dorr M, Nauck M, et al. Serum androgen concentrations and subclinical measures of cardiovascular disease in men and women. Atherosclerosis. 2016;247:193\u2013200.","journal-title":"Atherosclerosis."},{"key":"323_CR28","first-page":"645","volume":"85","author":"GA Laughlin","year":"2000","unstructured":"Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo study. J Clin Endocrinol Metab. 2000;85:645\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.ijir.3901504","volume":"19","author":"GM Rosano","year":"2007","unstructured":"Rosano GM, Sheiban I, Massaro R, Pagnotta P, Marazzi G, Vitale C, et al. Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res. 2007;19:176\u201382.","journal-title":"Int J Impot Res"},{"key":"323_CR30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrcardio.2009.105","volume":"6","author":"C Vitale","year":"2009","unstructured":"Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol. 2009;6:532\u201342.","journal-title":"Nat Rev Cardiol"},{"key":"323_CR31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20091924","volume":"207","author":"DP Sieveking","year":"2010","unstructured":"Sieveking DP, Lim P, Chow RWY, Dunn LL, Bao S, McGrath KCY, et al. A sex-specific role for androgens in angiogenesis. J Exp Med. 2010;207:345.","journal-title":"J Exp Med"},{"key":"323_CR32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11892-003-0020-2","volume":"3","author":"W Aldhahi","year":"2003","unstructured":"Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Current Diabetes Reports. 2003;3:293\u20138.","journal-title":"Current Diabetes Reports"},{"key":"323_CR33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","volume":"125","author":"AP Furnary","year":"2003","unstructured":"Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007\u201321.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"323_CR34","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","volume":"56","author":"F Iellamo","year":"2010","unstructured":"Iellamo F, Volterrani M, Caminiti G, Karam R, Massaro R, Fini M, et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Amer Coll Cardiol. 2010;56:1310\u20136.","journal-title":"J Amer Coll Cardiol"},{"key":"323_CR35","doi-asserted-by":"crossref","unstructured":"Vegunta S, Kling JM, Kapoor E. Androgen Therapy in Women. J Women's Health. 2019.","DOI":"10.1089\/jwh.2018.7494"},{"key":"323_CR36","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.jacc.2018.01.083","volume":"71","author":"D Zhao","year":"2018","unstructured":"Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, et al. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Amer Coll Cardiol. 2018;71:2555\u201366.","journal-title":"J Amer Coll Cardiol"},{"key":"323_CR37","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1042\/CS20170090","volume":"131","author":"AK Lucas-Herald","year":"2017","unstructured":"Lucas-Herald AK, Alves-Lopes R, Montezano Augusto C, Ahmed SF, Touyz RM. Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications. Clin Sci. 2017;131:1405\u201318.","journal-title":"Clin Sci"},{"key":"323_CR38","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1113\/JP277756","volume":"597","author":"CW Usselman","year":"2019","unstructured":"Usselman CW, Yarovinsky TO, Steele FE, Leone CA, Taylor HS, Bender JR, et al. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor. J Physiol. 2019;597:2853\u201365.","journal-title":"J Physiol"},{"issue":"19","key":"323_CR39","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1113\/jphysiol.2011.216218","volume":"589","author":"MM Wenner","year":"2011","unstructured":"Wenner MM, Taylor HS, Stachenfeld N. Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome. J Physiol. 2011;589(19):4671\u20139.","journal-title":"J Physiol"},{"key":"323_CR40","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.1152\/ajpendo.00343.2013","volume":"305","author":"MM Wenner","year":"2013","unstructured":"Wenner MM, Taylor HS, Stachenfeld NS. Androgens influence microvascular dilation in PCOS through ET-A and ET-B receptors. Amer J Physiol Endocrinol Metab. 2013;305:E818\u2013E25.","journal-title":"Amer J Physiol Endocrinol Metab"},{"key":"323_CR41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cen.13808","volume":"89","author":"S Shorakae","year":"2018","unstructured":"Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, de Courten B, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol. 2018;89:628\u201333.","journal-title":"Clin Endocrinol"},{"key":"323_CR42","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","volume":"90","author":"M Kravariti","year":"2005","unstructured":"Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:5088\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456\u201388.","journal-title":"Fertil Steril"},{"key":"323_CR44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijcard.2014.06.079","volume":"176","author":"SA Anderson","year":"2014","unstructured":"Anderson SA, Barry JA, Hardiman PJ. Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Cardiol. 2014;176:486\u20137.","journal-title":"Int J Cardiol"},{"key":"323_CR45","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.99.17.2317","volume":"99","author":"JA McCrohon","year":"1999","unstructured":"McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation. 1999;99:2317\u201322.","journal-title":"Circulation."},{"key":"323_CR46","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","volume":"103","author":"G Paradisi","year":"2001","unstructured":"Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103:1410\u20135.","journal-title":"Circulation."},{"key":"323_CR47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","volume":"164","author":"K Bajuk Studen","year":"2011","unstructured":"Bajuk Studen K, \u0160ebe\u0161tjen M, Pfeifer M, Pre\u017eelj J. Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome. Eur J Endocrinol. 2011;164:389\u201395.","journal-title":"Eur J Endocrinol"},{"key":"323_CR48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cen.14132","volume":"92","author":"BI Gulanski","year":"2020","unstructured":"Gulanski BI, Flannery CA, Peter PR, Leone CA, Stachenfeld NS. Compromised endothelial function in transgender men taking testosterone. Clin Endocrinol. 2020;92:138\u201344.","journal-title":"Clin Endocrinol"},{"key":"323_CR49","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JOE-12-0582","volume":"217","author":"DM Kelly","year":"2013","unstructured":"Kelly DM, Jones TH. Testosterone: a vascular hormone in health and disease. J Endocrinol. 2013;217:R47\u201371.","journal-title":"J Endocrinol"},{"key":"323_CR50","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95:2038\u201349.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411\u20135.","journal-title":"Nature."},{"key":"323_CR52","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1073\/pnas.86.8.2863","volume":"86","author":"A Inoue","year":"1989","unstructured":"Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989;86:2863\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"323_CR53","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","volume":"86","author":"E Diamanti-Kandarakis","year":"2001","unstructured":"Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I. Increased endothelial-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab. 2001;86:4666\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR54","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1249\/MSS.0b013e3181d8cf68","volume":"42","author":"NS Stachenfeld","year":"2010","unstructured":"Stachenfeld NS, Yeckel CW, Taylor HS. Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls. Med Sci Sports Exerc. 2010;42:1660\u20138.","journal-title":"Med Sci Sports Exerc"},{"key":"323_CR55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.rbmo.2017.03.018","volume":"35","author":"J Gui","year":"2017","unstructured":"Gui J, Wang R-H. Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod BioMed Online. 2017;35:113\u201320.","journal-title":"Reprod BioMed Online"},{"key":"323_CR56","first-page":"27","volume":"13","author":"ZH Hashim","year":"2015","unstructured":"Hashim ZH, Hamdan FB, Al-Salihi AR. Autonomic dysfunction in women with polycystic ovary syndrome. Iran J Reprod Med. 2015;13:27\u201334.","journal-title":"Iran J Reprod Med"},{"key":"323_CR57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/07435800.2014.920350","volume":"40","author":"S Kuppusamy","year":"2015","unstructured":"Kuppusamy S, Pal GK, Habeebullah S, Ananthanarayanan PH, Pal P. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome. Endocr Res. 2015;40:37\u201343.","journal-title":"Endocr Res"},{"key":"323_CR58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.12003","volume":"77","author":"A Lansdown","year":"2012","unstructured":"Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin Endocrinol. 2012;77:791\u2013801.","journal-title":"Clin Endocrinol"},{"key":"323_CR59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/ebm.2009.009186","volume":"235","author":"EJ Adkisson","year":"2010","unstructured":"Adkisson EJ, Casey DP, Beck DT, Gurovich AN, Martin JS, Braith RW. Central, peripheral and resistance arterial reactivity: fluctuates during the phases of the menstrual cycle. Exp Biol Med. 2010;235:111\u20138.","journal-title":"Exp Biol Med"},{"key":"323_CR60","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1152\/ajpendo.00725.2007","volume":"294","author":"YB Sverrisdottir","year":"2008","unstructured":"Sverrisdottir YB, Mogren T, Kataoka J, Janson PO, Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab. 2008;294:E576\u201381.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"323_CR61","volume-title":"Woodington K, et al","author":"EA Lambert","year":"2015","unstructured":"Lambert EA, Teede H, Sari CI, Jona E, Shorakae S. Woodington K, et al. Clin Endocrinol (Oxf): Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance; 2015."},{"key":"323_CR62","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GRF.0000000000000398","volume":"61","author":"MB Moravek","year":"2018","unstructured":"Moravek MB. Gender-affirming hormone therapy for transgender men. Clin Obstet Gynecol. 2018;61:687\u2013704.","journal-title":"Clin Obstet Gynecol"},{"key":"323_CR63","volume-title":"How many adults identify as transgender in the United States?","author":"AHJ Flores","year":"2016","unstructured":"Flores AHJ, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? Los Angeles: The Williams Institute; 2016."},{"key":"323_CR64","unstructured":"WPATH. WPATH Clarification on Medical Necessity of Treatment, Sex Reassignment, and Insurance Coverage for Transgender and Transsexual People Worldwide. 2014."},{"key":"323_CR65","volume-title":"The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding","author":"Medicine Io","year":"2011","unstructured":"Medicine Io. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington, DC: Institute of Medicine; 2011."},{"key":"323_CR66","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, et al. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2017;102:3914\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"323_CR67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M17-0577","volume":"167","author":"CG Streed Jr","year":"2017","unstructured":"Streed CG Jr, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M. Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review. Ann Intern Med. 2017;167:256\u201367.","journal-title":"Ann Intern Med"},{"key":"323_CR68","doi-asserted-by":"crossref","unstructured":"Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheught FWA, Gooren LJG. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;1995.","DOI":"10.7326\/0003-4819-118-6-199303150-00006"},{"key":"323_CR69","doi-asserted-by":"crossref","unstructured":"Irwig MS. Cardiovascular health in transgender people. Rev Endocr Metab Disord. 2018.","DOI":"10.1007\/s11154-018-9454-3"},{"key":"323_CR70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.endonu.2015.02.001","volume":"62","author":"C Quiros","year":"2015","unstructured":"Quiros C, Patrascioiu I, Mora M, Aranda GB, Hanzu FA, Gomez-Gil E, et al. Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia. Endocrinol Nutr. 2015;62:210\u20136.","journal-title":"Endocrinol Nutr"},{"key":"323_CR71","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1447-0756.2008.00857.x","volume":"34","author":"Y Emi","year":"2008","unstructured":"Emi Y, Adachi M, Sasaki A, Nakamura Y, Nakatsuka M. Increased arterial stiffness in female-to-male transsexuals treated with androgen. J Obstet Gynaecol Res. 2008;34:890\u20137.","journal-title":"J Obstet Gynaecol Res"},{"key":"323_CR72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpsychores.2015.02.001","volume":"78","author":"M Colizzi","year":"2015","unstructured":"Colizzi M, Costa R, Scaramuzzi F, Palumbo C, Tyropani M, Pace V, et al. Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2\u2009year follow-up study. J Psychosom Res. 2015;78:399\u2013406.","journal-title":"J Psychosom Res"},{"key":"323_CR73","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med. 2014;11:1999\u20132011.","journal-title":"J Sex Med"},{"key":"323_CR74","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","volume":"58","author":"JM Elbers","year":"2003","unstructured":"Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol. 2003;58:562\u201371.","journal-title":"Clin Endocrinol"},{"key":"323_CR75","first-page":"e56","volume":"139","author":"J Benjamin Emelia","year":"2019","unstructured":"Benjamin Emelia J, Muntner P, Alonso A, Bittencourt Marcio S, Callaway Clifton W, Carson April P, et al. Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association. Circulation. 2019;139:e56\u2013e528.","journal-title":"Circulation."},{"key":"323_CR76","doi-asserted-by":"crossref","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","volume":"300","author":"DH Thijssen","year":"2011","unstructured":"Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2\u201312.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"323_CR77","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.amjcard.2015.11.063","volume":"117","author":"JL Anderson","year":"2016","unstructured":"Anderson JL, May HT, Lapp\u00e9 DL, Bair T, Le V, Carlquist JF, et al. Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system. Am J Cardiol. 2016;117:794\u20139.","journal-title":"Am J Cardiol"},{"key":"323_CR78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sxmr.2017.10.001","volume":"6","author":"AM Traish","year":"2018","unstructured":"Traish AM. Benefits and health implications of testosterone therapy in men with testosterone deficiency. Sex Med Rev. 2018;6:86\u2013105.","journal-title":"Sex Med Rev"},{"key":"323_CR79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","volume":"15","author":"BT Palmisano","year":"2018","unstructured":"Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Molecular Metabolism. 2018;15:45\u201355.","journal-title":"Molecular Metabolism"},{"key":"323_CR80","doi-asserted-by":"crossref","unstructured":"Chandra P, Basra SS, Chen TC, Tangpricha V. Alterations in lipids and adipocyte hormones in female-to-male transsexuals. Int J Endocrinol. 2010;2010.","DOI":"10.1155\/2010\/945053"},{"key":"323_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","volume":"72","author":"MB Elamin","year":"2010","unstructured":"Elamin MB, Garcia MZ, Murad MH, Erwin PJ, Montori VM. Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses. Clin Endocrinol. 2010;72:1\u201310.","journal-title":"Clin Endocrinol"},{"key":"323_CR82","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S, Singh ON, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, et al. Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2017;102:3914\u201323.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"323_CR83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinchem\/36.2.283","volume":"36","author":"RA Wild","year":"1990","unstructured":"Wild RA, Applebaum-Bowden D, Demers LM, Bartholomew M, Landis JR, Hazzard WR, et al. Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem. 1990;36:283.","journal-title":"Clin Chem"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-020-00323-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-020-00323-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-020-00323-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:45:45Z","timestamp":1627515945000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-020-00323-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1186\/s13293-020-00323-6","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent for the <i>Biology of Sex Differences<\/i> to publish this material.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}